Wells Fargo, JPMorgan Chase, and More Set to Report

Shares of JPMorgan Chase & Co. JPM rallied 1.33% to $247.47 Tuesday, on what proved to be an all-around great trading session ...
Eight blockbuster drugs are expected to generate over $3bn in peak sales each according to Novartis CEO Vas Narasimhan.
Spain's Almirall has announced strategic plans at the 43rd JP Morgan Healthcare Conference based on expected double-digit ...
JP Morgan’s James Sullivan says that China's muted growth outlook should not bar investors from wading into the markets there ...
Amgen CEO Robert Bradway said the company's obesity drug could find its space in the market due to once-monthly dosing and ...
Key Insights Institutions' substantial holdings in JPMorgan Chase implies that they have significant influence over ...
The biggest banks in the U.S. are expected to report this week that they drove far higher profits in the fourth quarter than ...
Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024 ...